Mohammad Ahmadasas

Dr. Mohammad Ahmadasas

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 July 2024 in Signals
Verified
Journal Article
Open access
PDF file
Mahmoud Motaz Abdel LatifMahmoud Motaz Abdel Latif
Mahmoud Motaz Abdel Latif
Mudassir M. RashidMudassir M. Rashid
Mudassir M. Rashid
MAMohammad Reza Reza Askari
Mohammad Reza Reza Askari
ASAndrew Shahidehpour
Andrew Shahidehpour
MAMohammad Ahmadasas
Mohammad Ahmadasas
ACAli Cinar
Ali Cinar
Acute psychological stress (APS) is a complex and multifactorial phenomenon that affects metabolism, necessitating real-time detection and interventions to mitigate its effects on glycemia in people with type 1 diabetes. This study investigates the detection of APS using physiological variables measured by the Empatica E4 wristband and employs explainable machine learning to evaluate the importance of the physiological signals. The extreme gradient boosting model is developed for classification of APS and non-stress (NS) with weighted training, achieving an overall accuracy of 99.93%. The Shapley additive explanations (SHAP) technique is employed to interpret the global importance of the physiological signals, determining the order of importance for the variables from most to least as galvanic skin response (GSR), heart rate (HR), skin temperature (ST), and motion sensors (accelerometer readings). The increase in GSR and HR are positively correlated with the occurrence of APS as indicated by high positive SHAP values. The SHAP technique is also used to explain the local signal importance for particular instances of misclassified samples. The detection of APS can inform multivariable automated insulin delivery systems to intervene to counteract the APS-induced glycemic excursions in people with type 1 diabetes.

6 July 2023 in Endocrines
Verified
Journal Article
Open access
PDF file
ASAndrew Shahidehpour
Andrew Shahidehpour
Mudassir M. RashidMudassir M. Rashid
Mudassir M. Rashid
MAMohammad Reza Reza Askari
Mohammad Reza Reza Askari
MAMohammad Ahmadasas
Mohammad Ahmadasas
ACAli Cinar
Ali Cinar
Impaired glucagon secretion is a major component of glucose intolerance in type 2 diabetes mellitus (T2D). Glucagon secretion exhibits heterogenous patterns in individuals and across glucose tolerance diagnoses. Characterization of the range of glucagon secretion patterns can help clinicians personalize diabetes care based on glucagon characteristics in addition to glucose and insulin profiles. A total of 102 subjects with normal glucose tolerance, impaired glucose tolerance, and T2D had their glucagon profiles recorded in response to an oral glucose tolerance test. Shapelet analysis was used to identify the most descriptive patterns of early glucagon secretion, and spectral biclustering was employed to identify biclusters of associated subjects and shapelets. The dynamics of glucose, insulin, and glucagon secretion in each cluster were evaluated to identify overall patterns, and the characteristics of the subjects in each cluster were compared. Three clusters were chosen to represent the glucagon patterns. Membership in these three clusters was interpreted based on the presence or lack of extrema in the first 30 min after oral carbohydrate intake. Cluster 1 (n = 23) had a minimum at 30 min and only negative trends. Cluster 2 had a minimum at 10 min and a maximum at 20 min (n = 25). Cluster 3 (n = 40) had a maximum at 10 min and a minimum at 20 min. Subjects in cluster 1 had the lowest average fasting plasma glucose (90.17 mg/dL) and average age (41.39 years) and the highest HOMA-beta score (87.5%), while subjects in cluster 2 had the highest average fasting plasma glucose (102.56 mg/dL) and average age (53.16 years) and the lowest HOMA-beta score (55.77%). Characterization of glucagon dynamics, in addition to glucose and insulin, can aid in personalized treatment approaches and provide greater insight about the underlying dysfunction in glucose regulation.